Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular profiles of endometrial cancer tumors among Black patients.

Gynecologic oncology - 1 Jul 2022

Wilhite Annelise M, Baca Yasmine, Xiu Joanne, Paladugu Rajesh, ElNaggar Adam C, Brown Jubilee, Winer Ira S, Morris Robert, Erickson Britt K, Olawaiye Alexander B, Powell Matthew, Korn W Michael, Rocconi Rodney P, Khabele Dineo, Jones Nathaniel L

Abstract excerpt

OBJECTIVES: Disparate outcomes exist between Black and White patients with endometrial cancer (EC). One contributing factor is the disproportionately low representation of Black patients in clinical trials and in tumor molecular profiling studies. Our objective was to investigate molecular profiles of ECs in a cohort with a high proportion of tumors from Black patients. METHODS: A total of 248 EC samples and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black People
Share to Carcinoma, Endometrioid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinosarcoma

Share to Endometrial Neoplasms

Share to Microsatellite Instability

Share to Mutation

Source

Identifiers

PMID: 35490034
DOI: 10.1016/j.ygyno.2022.04.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular profiles of endometrial cancer tumors among Black patients.PMID 35490034Read ↗

Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic ImplicationsSemantic proximity Read ↗

TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes.Semantic proximity Read ↗

Epigenetic mechanisms underlying endometrial cancer outcomes: race-specific patterns of DNA methylation associated with molecular subtypes and survivalSemantic proximity Read ↗

Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study.Semantic proximity Read ↗

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2).Semantic proximity Read ↗

Genomic Characterization of High-Grade Serous Ovarian Carcinoma Reveals Distinct Somatic Features in Black Individuals.Semantic proximity Read ↗

Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial CancerSemantic proximity Read ↗

Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata.Semantic proximity Read ↗

Racial disparities in molecular subtypes of endometrial cancerSemantic proximity Read ↗

Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancerSemantic proximity Read ↗

The DNA damage repair landscape in Black women with breast cancerSemantic proximity Read ↗

Comprehensive Molecular Characterization of High-Grade Endometrial Cancer in an Ancestrally-Diverse CohortSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.